Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics Bernd Meibohm Commentary 12 September 2014 Pages: 863 - 864
Pharmacokinetic Enhancers in HIV Therapeutics Kajal B. LarsonKun WangEdward P. Acosta Leading Article 28 August 2014 Pages: 865 - 872
Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults Kyle John WilbyMary H. H. EnsomFawziah Marra Review Article 30 August 2014 Pages: 873 - 890
Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous System Andrea CalcagnoGiovanni Di PerriStefano Bonora Review Article 09 September 2014 Pages: 891 - 906
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers: Integrated Analysis of Intravenous and Subcutaneous, Single- and Multiple-Dose Administration Ahmed A. OthmanJonathan Q. TranSandeep Dutta Original Research Article 12 September 2014 Pages: 907 - 918
Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach Célia Lloret-LinaresDéborah HirtXavier Declèves Original Research Article 21 August 2014 Pages: 919 - 930
Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers Margreke J. E. BrillAnne van RongenCatherijne A. J. Knibbe Original Research Article Open access 21 August 2014 Pages: 931 - 941
Population Pharmacokinetics of Rabeprazole and Dosing Recommendations for the Treatment of Gastroesophageal Reflux Disease in Children Aged 1–11 Years Sarah C. McLeayBruce GreenHolly Kimko Original Research Article 29 August 2014 Pages: 943 - 957
Erratum to: Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition Zhe-Yi HuAndrea N. EdgintonRobert B. Parker Erratum 21 August 2014 Pages: 959 - 959